Admission Date:  [**2117-3-9**]              Discharge Date:   [**2117-3-22**]   Service: CARDIOTHORACIC  Allergies: Patient recorded as having No Known Allergies to Drugs  Attending:[**First Name3 (LF) 1283**] Chief Complaint: DOE/fatigue and decreased exercise tolerance  Major Surgical or Invasive Procedure: redo sternotomy/AVR ( 21mm [**Company 1543**] Mosaic porcine valve)/MVR ( 25 mm [**Company 1543**] Mosaic porcine valve) [**2117-3-9**]   History of Present Illness: 87 yo female with prior cabg in [**2109**].
Initially seen by Dr. [**Last Name (STitle) 1290**] [**1-28**] and now presents for surgical repair.
hip surgeries with left THR [**2101**] prior bladder suspension prior TAH prior cataract surgery  Social History: retired homemaker never used tobacco denies ETOH lives with husband   Family History: not known  Physical Exam: HR 74   142/67  100% sat O2 58"   90# NAD skin/HEENT unremarkable bil.
carotids transmitted murmur vs. bruits  Discharge Vitals 98.7, 92/40, 86, 18, 94 RA, Wt 38.5kg Neuro Alert and oriented Pulm CTA bilat Cardiac RRR Sternal inc no drainage/erythema Abd Soft, NT, ND, + BS Ext warm, no edema   Pertinent Results: [**2117-3-21**] 02:57PM BLOOD WBC-11.1* RBC-3.22* Hgb-9.6* Hct-28.5* MCV-89 MCH-29.8 MCHC-33.7 RDW-19.2* Plt Ct-355 [**2117-3-9**] 01:44PM BLOOD WBC-11.7*# RBC-3.35* Hgb-10.0* Hct-28.4* MCV-85 MCH-29.9 MCHC-35.1* RDW-19.2* Plt Ct-113* [**2117-3-22**] 06:30AM BLOOD PT-12.2 INR(PT)-1.0 [**2117-3-21**] 02:57PM BLOOD Plt Ct-355 [**2117-3-9**] 01:44PM BLOOD Plt Ct-113* [**2117-3-9**] 01:44PM BLOOD PT-18.1* PTT-54.8* INR(PT)-1.7* [**2117-3-22**] 06:30AM BLOOD Glucose-94 UreaN-44* Creat-1.9* Na-135 K-4.2 Cl-101 HCO3-29 AnGap-9 [**2117-3-9**] 02:55PM BLOOD UreaN-28* Creat-1.1 Cl-112* HCO3-21* [**2117-3-16**] 03:07AM BLOOD ALT-7 AST-22 LD(LDH)-252* AlkPhos-96 TotBili-0.5 [**2117-3-22**] 06:30AM BLOOD Calcium-10.0 Phos-3.5 Mg-2.1 [**2117-3-22**] 06:30AM BLOOD Phenyto-15.9 [**2117-3-15**] 04:53AM BLOOD Phenyto-30.7* [**2117-3-12**] 02:42AM BLOOD Phenyto-12.5  RADIOLOGY  Final Report  CHEST (PA & LAT)  [**2117-3-22**] 8:57 AM  CHEST (PA & LAT)  Reason: evaluate rt effusion  [**Hospital 93**] MEDICAL CONDITION: 87 year old woman s/p AVR, MVR REASON FOR THIS EXAMINATION: evaluate rt effusion HISTORY: 87-year-old female status post AVR/MVR.
Compared to the previous tracing of [**2117-3-9**] there is variation in precordial lead placement and ST-T wave flattening.
Read by: [**Last Name (LF) 578**],[**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 579**]    Intervals Axes Rate PR QRS QT/QTc P QRS T 97 164 84 322/376.57 61 14 104     RADIOLOGY  Final Report  MR HEAD W/O CONTRAST  [**2117-3-16**] 1:36 PM  MR HEAD W/O CONTRAST; MRA BRAIN W/O CONTRAST  Reason: r/o cva  [**Hospital 93**] MEDICAL CONDITION: 87 year old woman s/p AVR/MVR c/b MS changes REASON FOR THIS EXAMINATION: r/o cva INDICATION: AVR/MVR, mental status changes.
[**Hospital 93**] MEDICAL CONDITION: 87 year old woman with post Aortic and mitral valve replacement, new seizure REASON FOR THIS EXAMINATION: Stroke?
INDICATION: 87-year-old woman with post-aortic and mitral valve placement, new seizure, question stroke.
However, this can be confirmed with a repeat MRI with diffusion-weighted images, based on clinical discretion.
ABNORMALITY #3: Bursts of generalized intermixed theta and delta  slowing were noted in the waking state.
Status: Inpatient Date/Time: [**2117-3-9**] at 11:05 Test: TEE (Complete) Doppler: Full Doppler and color Doppler Contrast: None Tape Number: 2007AW01-: Test Location: Anesthesia West OR cardiac Technical Quality: Adequate     REFERRING DOCTOR: DR. [**First Name (STitle) 412**] [**Last Name (Prefixes) 413**]  MEASUREMENTS: Left Ventricle - Septal Wall Thickness: 0.9 cm (nl 0.6 - 1.1 cm)  Left Ventricle - Inferolateral Thickness: 0.9 cm (nl 0.6 - 1.1 cm) Left Ventricle - Diastolic Dimension: 4.0 cm (nl <= 5.6 cm) Left Ventricle - Ejection Fraction: 50% to 55% (nl >=55%) Aorta - Ascending: 3.2 cm (nl <= 3.4 cm) Aorta - Descending Thoracic: 2.5 cm (nl <= 2.5 cm) Aortic Valve - Peak Gradient: 26 mm Hg Aortic Valve - Mean Gradient: 16 mm Hg Aortic Valve - LVOT Diam: 1.9 cm Aortic Valve - Valve Area: *0.6 cm2 (nl >= 3.0 cm2)  INTERPRETATION:  Findings:  LEFT ATRIUM: Normal LA size.
LV WALL MOTION: basal anterior - normal; mid anterior - normal; basal anteroseptal - normal; mid anteroseptal - normal; basal inferoseptal - normal; mid inferoseptal - normal; basal inferior - normal; mid inferior - normal; basal inferolateral - normal; mid inferolateral - normal; basal anterolateral - normal; mid anterolateral - normal; anterior apex - normal; septal apex - normal; inferior apex - normal; lateral apex - normal; apex - normal;  RIGHT VENTRICLE: Normal RV chamber size and free wall motion.
Severely thickened/deformed aortic valve leaflets.
The patient received antibiotic prophylaxis.
The patient was under general anesthesia throughout the procedure.
Postbypass: on Phenylephrine and Epinephrine ggt 0.02 - There is a prosthetic valve well seated in the mitral position, without perivalvular leak Mitral valve gradient of 4 mmHg.
Clinical: Aortic stenosis/aortic and mitral valve replacement.
Part 1 is additionally labeled "aortic valve leaflets" and consists of three leaflets with calcification measuring 2 x 1.2 x 0.1, and 1.7 x 1.1 x 0.1 and 1.9 x 1 x 0.1 cm, respectively represented in A after decalcification.
Brief Hospital Course: Admitted [**3-9**] and underwent redo AVR/MVR with Dr. [**Last Name (STitle) 1290**].
Transferred to the CSRU in stable condition on epinephrine and propofol drips.
Neuro consult obtained and ativan given, dilantin loaded.
MRI with questionable occipital CVA.HIT screen sent for plt.
Dilantin held while level was supratherapeutic.
MRI [**3-16**] showed chronic microvascular ischemic changes.Tube feeds started [**3-17**] and NG tube removed [**3-18**].
Medications on Admission: ASA 81 mg daily toprol XL 100 mg daily lipitor 10 mg daily lisinopril 5 mg daily protonix 40 mg dily lasix 20 mg daily KCl K-phos calcitrol SL NTG prn  Discharge Medications: 1.
Furosemide 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Potassium Chloride 10 mEq Capsule, Sustained Release Sig: Two (2) Capsule, Sustained Release PO DAILY (Daily).
Metoprolol Tartrate 50 mg Tablet Sig: One (1) Tablet PO TID (3 times a day).
Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day).
Calcitriol 0.5 mcg Capsule Sig: Four (4) Capsule PO DAILY (Daily).
Atorvastatin 10 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Pantoprazole 40 mg Tablet, Delayed Release (E.C.)
Aspirin 81 mg Tablet, Delayed Release (E.C.)
Ampicillin 500 mg Capsule Sig: One (1) Capsule PO every six (6) hours for 7 days.
Phenytoin 50 mg Tablet, Chewable Sig: Two (2) Tablet, Chewable PO TID (3 times a day): check level q2days with goal [**8-30**] and no signs of clinical toxicity, for further dosing.
Discharge Disposition: Extended Care  Facility: [**Hospital3 1107**] [**Hospital **] [**Hospital 1108**] Rehab Unit at [**Hospital6 1109**] - [**Location (un) 1110**]  Discharge Diagnosis: s/p redo AVR/MVR Seizure disorder CABG X4   [**2109**] HTN [**Year (4 digits) **].
hip surgeries s/p bladder suspension TAH cataract surgery seizure   Discharge Condition: good  Discharge Instructions: may shower over incisions and pat dry no lotions, creams or powders on any incision no driving for one month or until visit to surgeon no lfting greater than 10 pounds for 10 weeks call for fever greater than 100.5, redness or drainage  Followup Instructions: see Dr. [**Last Name (STitle) 9960**] in [**11-17**] weeks see Dr. [**First Name (STitle) 1075**] in [**12-19**] weeks see Dr. [**Last Name (STitle) 1290**] in 4 weeks   [**Telephone/Fax (1) 170**] Neuro: [**Name6 (MD) **] [**Name8 (MD) 8222**], MD Phone:[**Telephone/Fax (1) 3294**] Date/Time:[**2117-4-5**] 8:30 [**Hospital Ward Name 23**] 8 Labs: dilantin level q2day with goal range 10-15 and no signs of clinical toxicity, dose may need to be adjusted    Completed by:[**2117-3-22**
